NL-OMON22488招募中不适用
Potential effect of proton-pump inhibitor on angiogenic markers in preeclampsia
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- one
- 入组人数
- 44
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Women (=18 years) with a singleton pregnancy diagnosed with PE with a gestational age of = 20 weeks and <35 weeks admitted to the obstetric department who give written informed consent, will be included.
排除标准
- •- Multiple pregnancies
- •- Not willing to give written informed consent.
- •- Other reasons than (suspected) PE requiring hospitalization
- •- The use of PPI at time of randomization
- •- Contraindications or hypersensitivity to PPI use
- •- The use of medication affected by PPI
- •- Fetal death at time of inclusion
- •- Signs of fetal distress at time of inclusion
- •- Expected delivery of = 2 days
研究者
相似试验
进行中(未招募)
1 期
The effect of gastric reflux medication on biomarkers in toxemia of pregnancyAngiogenic markers in preeclampsiaEUCTR2018-000283-28-NL44
招募中
4 期
Potential effect of proton-pump inhibitor on angiogenic markers in preeclampsiaToxemia of Pregnancy10010273NL-OMON50177Erasmus MC, Universitair Medisch Centrum Rotterdam44
已完成
不适用
The influence of proton pump inhibitor therapy on the clinical course of COVID-19SARS-CoV2J12.8J80.0Other viral pneumoniaDRKS00021523niversitätsklinikum Freiburg, Klinik für Innere Medizin II152
已完成
不适用
The effect of proton pump inhibitor and potassium competitive acid blocker toward endothelial cells.healthy adultsJPRN-UMIN000024875Hamamatsu University School of Medicine70
未知
不适用
Research on the effect of a proton pump inhibitor on the oral and intestinal microbiota and salivary protein and metabolites.healthy volunteerJPRN-UMIN000025331Shimane university24
